from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Record returned to U.S.D.C. Southern District of New York. 3 Boxes.
JUDGMENT ISSUED.
Application (14A792) denied without prejudice by Justice Breyer.
Application (14A792) for issuance of the mandate forthwith, submitted to Justice Breyer.
Judgment VACATED and case REMANDED. Breyer, J., delivered the opinion of the Court, in which Roberts, C. J., and Scalia, Kennedy, Ginsburg, Sotomayor, and Kagan, JJ., joined. Thomas, J., filed a dissenting opinion, in which Alito, J., joined.
Argued. For petitioners: William M. Jay, Washington, D. C. For United States, as amicus curiae: Ginger D. Anders, Assistant to the Solicitor General, Washington, D. C. For respondents: Carter G. Phillips, Washington, D. C.
Reply of petitioners Teva Pharmaceuticals USA, Inc., et al. filed. (Distributed)
Brief amici curiae of Google Inc., et al. filed. (Distributed)
Brief amici curiae of Intel Corporation, et al. filed. (Distributed)
Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed.
CIRCULATED.
Brief of respondents Sandoz, Inc., et al. filed.
Record received from U.S.D.C. Southern District of New York (3 Boxes), the records in this case are SEALED.
Record received from U.S.C.A. Federal Circuit. The record is located on PACER, confidential documents are filed electronically.
SET FOR ARGUMENT ON Wednesday, Octobert 15, 2014
Record requested from U.S.C.A. Federal Circuit.
Brief amici curiae of Professors Peter S. Menell, et al. in support of neither party filed.
Brief amicus curiae of American Intellectual Property Law Association in support of neither party filed.
Brief amicus curiae of Fresenius Kabi USA, LLC in support of neither party filed.
Brief amicus curiae of Houston Intellectual Property Law Association in support of neither party filed.
Brief amicus curiae of American Bar Association in support of neither party filed.
Brief amicus curiae of the United States in support of neither party filed.
Brief amicus curiae of Federation Internationale Des Conseils En Propriete Intellectuelle (FICPI) in support of neither party filed.
Joint appendix filed. (5 Volumes) (Statement of costs filed.)
Motion for leave to file Volume 4 of the joint appendix under seal filed by petitioners Teva Pharmaceuticals USA, Inc., et al.
Brief of petitioners Teva Pharmaceuticals USA, Inc., et al. filed.
Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for respondents Mylan Pharmaceuticals, Inc., et al.
The time to file respondents' brief on the merits is extended to and including August 11, 2014.
The time to file the joint appendix and petitioners' brief on the merits is extended to and including June 13, 2014.
Application (13A1003) denied by The Chief Justice. (In Chambers Opinion)
Reply of applicant Teva Pharmaceuticals USA, Inc., et al. filed.
Response to application from respondents and motion for leave to file under seal declarations in support of respondents filed.
Response to the application (13A1003) to recall and stay the mandate requested by The Chief Justice. The response is due Monday, April 14, 2014, by 5 p.m.
Application (13A1003) to recall and stay the mandate of the United States Court of Appeals for the Federal Circuit pending the sending down of the judgment of this Court, submitted to The Chief Justice.
Petition GRANTED.
Reply of petitioners Teva Pharmaceuticals USA, Inc., et al. filed. (Distributed)
Brief of respondents Sandoz, Inc., et al. in opposition filed.
Petition for a writ of certiorari filed. (Response due February 18, 2014)
Application (13A458) denied by The Chief Justice.
Reply of applicant Teva Pharmaceuticals USA, Inc., et al. filed.
Response to application from respondent Sandoz, Inc., et al. filed.
Response to the application (13A458) requested by The Chief Justice, due Tuesday, November 12, 2013, by 10 a.m.
Application (13A458) to recall and stay mandate pending the filing and disposition of a petition for a writ of certiorari, submitted to The Chief Justice.
Teva Pharmaceuticals USA, Inc., et al., Petitioner, represented by William M. Jay
Mylan Pharmaceuticals Inc., et al., Respondent, represented by Eric D. Miller
Mylan Pharmaceuticals Inc., et al., Respondent, represented by Carter G. Phillips
Sandoz, Inc., et al., Respondent, represented by Deanne E. Maynard
American Bar Association in support of neither party, Amicus Curiae, represented by James R. Silkenat
Federation Internationale Des Conseils En Propriete Intellectuelle (FICPI) in support of neither party, Amicus Curiae, represented by Maxim H. Waldbaum
Fresenius Kabi USA, LLC in support of neither party, Amicus Curiae, represented by Lawrence M. Sung
Google Inc., et al., Amicus Curiae, represented by Daryl L. Joseffer
Houston Intellectual Property Law Association in support of neither party, Amicus Curiae, represented by Peter Joseph Corcoran III.
Intel Corporation, et al., Amicus Curiae, represented by Thomas G. Hungar
Intellectual Property Owners Association in support of neither party, Amicus Curiae, represented by Paul H. Berghoff
Professors Peter S. Menell, et al. in support of neither party, Amicus Curiae, represented by Peter S. Menell
The American Intellectual Property Law Association in support of neither part, Amicus Curiae, represented by James D. Crowne
the United States in support of neither party, Amicus Curiae, represented by Donald B. Verrilli Jr.
United States, Amicus Curiae, represented by Ginger D. Anders